Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca F Valle

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
The Lancet. Oncology|March 6, 2025
Destroy or delay: hormonal therapy in oligometastatic prostate cancerAmar U Kishan, Luca F Valle
European Urology|May 3, 2021
Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010Luca F Valle, Amar U Kishan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2026
Reply to: Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate CancerLuca F Valle, Jeremie Calais, Amar U Kishan
European Urology|May 28, 2023
Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone TherapyTommy Jiang, Luca F Valle, Amar U Kishan
European Urology|October 7, 2023
Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate CancerAmar U Kishan, Luca F Valle, Leonard S Marks
Seminars in Radiation Oncology|December 17, 2023
MRI-Guided Radiation Therapy-An Emerging and Disruptive Process of Care: Healthcare Economic and Policy ConsiderationsP Travis Courtney, Luca F Valle, Ann C Raldow, et al.
Seminars in Radiation Oncology|December 17, 2023
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is BelievingRosalyne L Westley, Luca F Valle, Alison C Tree, et al.
Sarcoma|November 1, 2021
Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in SarcomaLuca F Valle, Nicholas Bernthal, Fritz C Eilber, et al.
Breast Cancer Research and Treatment|February 5, 2017
Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trialsLuca F Valle, Surbhi Agarwal, Kathleen E Bickel, et al.
The Oncologist|September 14, 2023
In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer"Luca F Valle, Nicholas G Nickols, Kosj Yamoah, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|March 6, 2025
Destroy or delay: hormonal therapy in oligometastatic prostate cancerAmar U Kishan, Luca F Valle
European Urology|May 3, 2021
Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010Luca F Valle, Amar U Kishan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2026
Reply to: Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate CancerLuca F Valle, Jeremie Calais, Amar U Kishan
European Urology|May 28, 2023
Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone TherapyTommy Jiang, Luca F Valle, Amar U Kishan
European Urology|October 7, 2023
Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate CancerAmar U Kishan, Luca F Valle, Leonard S Marks
Seminars in Radiation Oncology|December 17, 2023
MRI-Guided Radiation Therapy-An Emerging and Disruptive Process of Care: Healthcare Economic and Policy ConsiderationsP Travis Courtney, Luca F Valle, Ann C Raldow, et al.
Seminars in Radiation Oncology|December 17, 2023
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is BelievingRosalyne L Westley, Luca F Valle, Alison C Tree, et al.
Sarcoma|November 1, 2021
Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in SarcomaLuca F Valle, Nicholas Bernthal, Fritz C Eilber, et al.
Breast Cancer Research and Treatment|February 5, 2017
Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trialsLuca F Valle, Surbhi Agarwal, Kathleen E Bickel, et al.
The Oncologist|September 14, 2023
In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer"Luca F Valle, Nicholas G Nickols, Kosj Yamoah, et al.
Pageof 6